Search Results 881-890 of 16338 for Ureaplasma urealyticum

  1. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

    - Have a history of latent or active granulomatous infection, histoplasmosis, or coccidioidomycosis, or have had a nontuberculous mycobacterial infection prior ...

  2. Publications - Cumara B. O'Carroll, M.D., M.P.H. - Mayo Clinic

    HIV Infection and 90-Day Stroke Outcomes in Uganda: A Prospective Observational Cohort Study. Neurol Clin Pract. 2023 Dec; 13 (6):e200198 Epub 2023 Nov 06

  3. https://www.mayoclinic.org/patient_consumer_video.xml

  4. Teprotumumab-trbw (intravenous route) - Mayo Clinic

    unusual tiredness or weakness. Incidence not known. Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection ...

  5. Kidney Transplant Program - Conditions treated - Mayo Clinic

    High blood pressure (hypertension) · HIV/AIDS · Kidney infection · Kidney stones · Lupus · Multiple myeloma · Polycystic kidney disease · Scleroderma ...

  6. ENA test - Mayo Clinic

    The immune system usually makes antibodies to help the body fight infection. In contrast, antinuclear antibodies often attack the body's own tissues. If ...

  7. Eleanna O. De Filippis, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    General endocrinology; Diabetes and metabolism; Research interest in obesity and insulin resistance; Cardio-Endocrinology; Translational research in obesity ...

  8. Tumor Shrinking Nanoparticle used to Fight Cancer and Brain Tumors - Mayo Clinic

    Fund research. Save lives. ... Benefactor support fuels Mayo Clinic's groundbreaking research. Make a gift today to help us save lives. Give Today.

  9. Buerger disease - Diagnosis and treatment - Mayo Clinic

    Protect fingers and toes from cold and injury. Clean cuts and scrapes. A lack of blood flow to the arms and legs increases the risk of infection. Even small ...

  10. Cancer Treatment! Clinical Trials

    A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...